Philips expands AI partnership with Cortechs.ai to transform brain imaging diagnostics

THE NETHERLANDS—Royal Philips, a global health technology leader, has expanded its partnership with Cortechs.ai to integrate advanced AI-powered neuroimaging analytics directly into Philips’ MR systems.

This collaboration aims to provide clinicians with faster, more objective insights into brain health while streamlining diagnostic workflows.

The partnership combines Philips’ next-generation MR technology with Cortechs.ai’s AI-driven quantitative neuroimaging software to transform how doctors detect, monitor, and manage neurological diseases.

Brain scans account for up to 25% of all MR procedures, yet radiology departments face mounting pressure from staff shortages and rising patient numbers.

The prevalence of neurological conditions such as Alzheimer’s disease, multiple sclerosis, and brain tumors continues to grow worldwide, placing additional strain on already stretched healthcare systems.

Current MR interpretation relies heavily on visual assessment, which introduces variability and demands considerable expertise and time.

Philips and Cortechs.ai address this challenge by delivering standardized, data-driven imaging tools that provide objective numerical data alongside traditional images.

The integration includes brain volumetrics, lesion quantification, and tumor tracking capabilities that enable more consistent and confident diagnoses.

Cortechs.ai’s NeuroQuant® solutions for Alzheimer’s, multiple sclerosis, and brain tumors now operate within Philips’ Smart Reading environment—a cloud-based AI platform that combines imaging, reading, and reporting directly on MR systems.

This integration allows clinicians to automatically receive AI-generated quantitative reports within their standard MR workflow without adding extra steps for technologists.

The zero-click process ensures quality-checked data and standardized outputs, helping radiologists interpret brain scans more objectively and efficiently.

“By extending our partnership with Cortechs.ai, we are accelerating the transition to fully quantitative, AI-powered neuroimaging,” said Ioannis Panagiotelis, PhD, Business Leader for MRI at Philips.

“This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions.”

Kyle Frye, Chief Executive Officer of Cortechs.ai, emphasized that the company’s mission centers on empowering clinicians with actionable, quantitative insights.

“By combining our advanced neuro analytics with Philips’ leading MR platform and AI infrastructure, we are making it easier to personalize brain care and track neurological changes with precision,” he noted.

Cortechs.ai’s NeuroQuant® solutions are already available on Philips Advanced Visualization Workspace, and this expanded partnership reinforces Philips’ commitment to advancing neurological care through AI integration.